German cockroach allergens and patient immune components

German cockroach (Blattella germanica) allergens represent a complex group of proteins, including Bla g 1, Bla g 2 (an aspartic protease), and Bla g 5 (a glutathione S-transferase), that serve as potent triggers for IgE-mediated hypersensitivity (Pomés et al., 2017). These allergens interact with patient immune components, primarily allergen-specific IgE antibodies and Th2-polarized T-cells, to initiate and sustain chronic airway inflammation (Gao et al., 2022). Upon exposure, the allergens cross-link IgE bound to mast cells and basophils, leading to the release of inflammatory mediators like histamine and leukotrienes. This biological interaction is a primary driver of urban asthma and allergic rhinitis, often resulting in more severe disease phenotypes compared to other indoor allergens (NIH, 2021). Therapeutic strategies target this system by either sequestering the immune components, such as using Omalizumab to bind free IgE, or by modulating the immune response through allergen-specific immunotherapy (AIT) to induce long-term desensitization (FDA, 2023). Additionally, biologics like Dupilumab target the cytokine signaling pathways (IL-4/IL-13) that are activated by these allergens to reduce the underlying type 2 inflammation.

Other names

Blattella germanica allergensCockroach hypersensitivity componentsBla g proteinsCockroach-induced asthma components

Inhibition of IgE binding to high-affinity receptors on mast cells and basophils; blockade of IL-4 and IL-13 signaling to reduce Th2 inflammation; induction of immune tolerance through gradual allergen exposure in immunotherapy; inhibition of TSLP-mediated upstream inflammatory cascades.